OKLAHOMA SOCIETY OF CLINICAL ONCOLOGY I (EIN 731392619) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1985

Legal Domicile

Principal Officer

DR ADANMA AYANAMBAKKAM

Phone

4058508334

Tax Period

2024-07-01 to 2025-06-30

OKLAHOMA SOCIETY OF CLINICAL ONCOLOGY I, founded in 1985, is a small nonprofit that reported $197K in total revenue in fiscal year 2024. Revenue grew 11% year-over-year, indicating healthy expansion. Expenses of $181K left a modest 8% surplus.

Mission

TO IMPROVE SERVICES, PROMOTE EDUCATION, AND ADVANCE THE SCIENCES IN THE FIELD OF HEMATOLOGY AND ONCOLOGY AND ITS SUBSPECIALTIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $178,000

Investment Income $18,776

Other Revenue $0

TOTAL REVENUE $196,776

Expense Breakdown

Grants Paid $3,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $134,191

Other Expenses $178,275

TOTAL EXPENSES $181,275

Year-over-Year Comparison

	2024	2023	Change
Revenue	$196,776	$177,762	+0.1%
Expenses	$181,275	$187,466	0.0%
Net Income	$15,501	$-9,704	-2.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$18,667

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CHRISTINA E HENSON MD	BOARD MEMBER	1.00	Director	$0	$0	$0
JORDAN M MORTON MD	BOARD MEMBER	1.00	Director	$0	$0	$0
RAID ALJUMAILY MD	BOARD MEMBER	1.00	Director	$0	$0	$0
SUSANNA ULAHANNAN MD	BOARD MEMBER	1.00	Director	$0	$0	$0
ADANMA AYANAMBAKKAM MD	BOARD MEMBER	1.00	Director	$0	$0	$0
PAUL EL TOMB MD	BOARD MEMBER	1.00	Director	$0	$0	$0
SCOTT COLE MD	BOARD MEMBER	1.00	Director	$0	$0	$0
JOSE EUGENIO NAJERA MD	PRESIDENT	1.00	Officer	$0	$0	$0
WILLIAM C DOOLEY MD	TREASURER	1.00	Officer	$0	$0	$0
KATHLEEN A MUSSON CAE	EXECUTIVE DIRECTOR	20.00	Officer	$18,667	$0	$18,667

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$196,776	$181,275	$592,893	$15,501
2024	$177,762	$187,466	$557,971	$-9,704
2023	$178,124	$143,444	$554,719	$34,680
2022	$209,783	$136,065	$491,209	$73,718
2021	$204,617	$84,251	$492,590	$120,366
2020	$154,570	$115,985	$335,138	$38,585
2019	$162,201	$120,870	$302,063	$41,331
2018	$223,380	$146,484	$260,678	$76,896

OKLAHOMA SOCIETY OF CLINICAL ONCOLOGY I